Sign In

Lisa J. Herrinton, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3714 (phone)
lisa.herrinton@kp.org
Kaiser Permanente Researcher Profiles


 
Lisa Herrinton, PhD, is a senior research scientist and epidemiologist at the Kaiser Permanente Northern California Division of Research. She is a standing member of the Healthcare Outcomes and Effectiveness study section at the Agency for Healthcare Research and Quality (AHRQ) and has served on study section for the Centers for Disease Control, National Eye Institute, National Cancer Institute, and other federal agencies. Dr. Herrinton has 20 years of experience using a diverse range of research methods to investigate important questions in public health and health services. Most recently, she is conducing a program in implementation research, working with Kaiser Permanente physicians and health plan leaders to identify high priority topics suitable for integrating care delivery, quality improvement, and research. In addition, Dr. Herrinton is focused on using innovative approaches to realizing value from Kaiser Permanente's electronic medical record. These efforts cover diverse clinical areas including cataract surgery, oncology, and registry building across medical and surgical specialties. Earlier, she elucidated risk factors in the development of breast, ovarian, lung, and colorectal cancer, as well as lymphoma. In autoimmune disease, she built registries in inflammatory bowel disease, rheumatology, and psoriasis. Dr. Herrinton received her doctoral training at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Washington, and her master's training at Harvard University. She has published more than 160 peer-reviewed publications and several book chapters. In addition, she has led numerous collaborative activities and mentored many scientists and physician-investigators. Before her training in epidemiology, she was an environmental health manager. She also served as a high school science and math teacher through the Peace Corps in Swaziland, Africa. Besides her work, Dr. Herrinton enjoys her family and friends, hiking, biking, and swimming.

Current Position(s):

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California
  • Associate Editor, American Journal of Epidemiology

Section Affiliations:

Primary Research Interests:

  • Inflammatory bowel disease
  • Cancer
  • Etiology factors
  • Quality of care outcomes
  • Epidemiology methods
  • Outcomes research

    Evaluation of the Effectiveness and Implementation of Regionalized Care of Testicular Cancer

    This study has three primary aims: 1) to evaluate the effectiveness of Testicular Cancer Redesign on rates of use of guideline-adherent and avoidable utilization; 2) to evaluate users’ ability to adopt and maintain use of Testicular Cancer Redesign workflow changes and tools, guided by the RE-AIM framework, using information from audits, key-stakeholder interviews, and surveys; and 3) to identify contextual factors at the medical-center level that mediate the effectiveness and sustainability of implementation using interviews and surveys of key stakeholders, testing the hypothesis that implementation of the intervention will vary across medical centers because of differences in local context.
    Investigator: Herrinton, Lisa
    Funder: The Permanente Medical Group

    The Role of Bariatric Surgery in the Management of Nonalcoholic Fatty Liver Disease

    This project is proposed by University of California, San Francisco (UCSF) gastroenterology fellow Suzanne Sharpton, who is also earning an M.S. in public health. She is supported by Kaiser Permanente gastroenterologist Varun Saxton and bariatric surgeon Robert Li, as well as her UCSF mentor. The project has three specific aims. The first is to examine changes in hepatic fibrosis at baseline, 6, and 12 months post-surgery among morbidly obese adults who underwent bariatric surgery and had nonalcoholic steatohepatitis on a liver biopsy at baseline. The second is to compare the change in nonalcoholic fatty liver disease fibrosis score between Roux-en-Y gastric bypass versus sleeve gastrectomy. The third aim is to compare the rate of cardiovascular morbidity after bariatric surgery in morbidly obese adults with and without histologic evidence of nonalcoholic steatohepatitis at baseline.
    Investigator: Herrinton, Lisa
    Funder: East Bay Community Foundation

    FY16 Sentinel Infrastructure, Methods and Surveillance

    This project consists of tasks required for data partners in the Food and Drug Administration’s Sentinel Initiative under the initiative’s “Year 4 Infrastructure” statement of work. Most of the requirements involve data partner staff running data requests or returning data and documents of various types to the Sentinel Coordinating Center via the Sentinel PopMedNet Distributed Query Tool System.
    Investigator: Herrinton, Lisa
    Funder: U.S. Food and Drug Administration

    Predicting Final Visual Acuity Following Cataract Surgery

    The objective of this study is to predict visual acuity and incidence rates of complications after cataract surgery.
    Investigator: Herrinton, Lisa
    Funder: National Eye Institute

    Long-term Benefits and Risks of Bariatric Surgery in Integrated Care Systems

    The objective of this study is to provide surveillance of bariatric surgery outcomes and safety.
    Investigator: Herrinton, Lisa
    Funder: 

    M-S Data Expansion: Integration of Kaiser Permanente Hospital Data to the Sentinel Distributed Database

    Investigator: Herrinton, Lisa
    Funder: U.S. Food and Drug Administration
    No results found matching criteria

    An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches

    Author(s): Herrinton LJ; Ray GT; Curtis JR; Wu JJ; Fireman B; Liu L; Goldfien R

    Perm J. 2018 Jul 19;22.

    PubMed abstract

    Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection

    Author(s): Ge IY; Fevrier HB; Conell C; Kheraj MN; Flint AC; Smith DS; Herrinton LJ

    Ther Adv Urol. 2018 Oct;10(10):283-293. Epub 2018-06-22.

    PubMed abstract

    Association of Inflammatory Markers with Disease Progression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

    Author(s): Pan M; Alavi M; Herrinton LJ

    Perm J. 2018 Mar 30;22.

    PubMed abstract

    Large-Scale Implementation of Structured Reporting of Adnexal Masses on Ultrasound

    Author(s): Suh-Burgmann EJ; Flanagan T; Lee N; Osinski T; Sweet C; Lynch M; Caponigro M; Mehta J; Alavi M; Herrinton LJ

    J Am Coll Radiol. 2018 Mar 20.

    PubMed abstract

    Improving the quality of care and patient experience of care during the diagnosis of lupus: a qualitative study of primary care

    Author(s): Amsden LB; Davidson PT; Fevrier HB; Goldfien R; Herrinton LJ

    Lupus. 2018 Jan 01:961203318763082.

    PubMed abstract

    Immediate sequential bilateral cataract surgery: surgeon preferences and concerns

    Author(s): Amsden LB; Shorstein NH; Fevrier H; Liu L; Carolan J; Herrinton LJ

    Can J Ophthalmol. 2018 Aug;53(4):337-341. Epub 2017-12-27.

    PubMed abstract

    The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project

    Author(s): Dall'Era M; Cisternas MG; Snipes K; Herrinton LJ; Gordon C; Helmick CG

    2017 Oct;69(10):1996-2005. Epub 2017-09-10.

    PubMed abstract

    Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis

    Author(s): Alavi M; Wendel CS; Krouse RS; Temple L; Hornbrook MC; Bulkley JE; McMullen CK; Grant M; Herrinton LJ

    Ann Surg Oncol. 2017 Aug 07.

    PubMed abstract

    Participation in Activities Associated With Quality of Life for Long-Term Survivors of Rectal Cancer

    Author(s): Mcmullen C; Liu L; Bulkley JE; Hornbrook MC; Wendel C; Grant M; Altschuler A; Temple LK; Krouse RS; Herrinton L

    Perm J. 2017;21.

    PubMed abstract

    Immediate Sequential vs. Delayed Sequential Bilateral Cataract Surgery: Retrospective Comparison of Postoperative Visual Outcomes

    Author(s): Herrinton LJ; Liu L; Alexeeff S; Carolan J; Shorstein NH

    Ophthalmology. 2017 Apr 21.

    PubMed abstract

    Failure Modes and Effects Analysis of bilateral same-day cataract surgery

    Author(s): Shorstein NH; Lucido C; Carolan J; Liu L; Slean G; Herrinton LJ

    J Cataract Refract Surg. 2017 Mar;43(3):318-323.

    PubMed abstract

    Natural language processing to ascertain two key variables from operative reports in ophthalmology

    Author(s): Liu L; Shorstein NH; Amsden LB; Herrinton LJ

    Pharmacoepidemiol Drug Saf. 2017 Jan 03.

    PubMed abstract

    Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease

    Author(s): Brant SR; Herrinton LJ; Kugathasan S; et al.

    Gastroenterology. 2017 01;152(1):206-217.e2. Epub 2016-09-28.

    PubMed abstract

    Rectal Cancer Survivors' Participation in Productive Activities

    Author(s): Hornbrook MC; Grant M; Wendel C; Bulkley JE; Mcmullen CK; Altschuler A; Temple LK; Herrinton LJ; Krouse RS

    Perm J. 2017;22.

    PubMed abstract

    Pathogens and antibiotic sensitivities in endophthalmitis

    Author(s): Slean GR; Shorstein NH; Liu L; Paschal JF; Winthrop KL; Herrinton LJ

    Clin Experiment Ophthalmol. 2016 Dec 25.

    PubMed abstract

    Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery

    Author(s): Herrinton LJ; Shorstein NH; Paschal JF; Liu L; Contreras R; Winthrop KL; Chang WJ; Melles RB; Fong DS

    Ophthalmology. 2015 Oct 9.

    PubMed abstract

    Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery

    Author(s): Shorstein NH; Liu L; Waxman MD; Herrinton LJ

    Ophthalmology. 2015 Sep 23.

    PubMed abstract

    The Association of Refractive Error with Glaucoma in a Multiethnic Population

    Author(s): Shen L; Melles RB; Metlapally R; Barcellos L; Schaefer C; Risch N; Herrinton LJ; Wildsoet C; Jorgenson E

    Ophthalmology. 2015 Aug 7.

    PubMed abstract

    Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting

    Author(s): Curtis JR; Harrold LR; Asgari MM; Deodhar A; Salman C; Gelfand JM; Wu JJ; Herrinton LJ

    Perm J. 2016 Jul 29;20(4). Epub 2016-7-29.

    PubMed abstract

    The HMO research network

    Author(s): Chan KA; Davis RL; Gunter MJ; Gurwitz JH; Herrinton LJ; Nelson WW; Raebel MA; Roblin DW; Smith DH; Platt R

    In: Strom BL, editor. Pharmacoepidemiology, fourth edition. Chichester (UK): John Wiley & Sons; 2005.

    PubMed abstract

    Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis

    Author(s): Hutfless S; Abramson O; Heyman MB; Bayless TM; Li DK; Winthrop K; Herrinton LJ

    Gastroenterol Res Pract. 2015;2015:690581. Epub 2015-05-14.

    PubMed abstract

    Big Data, Miniregistries: A Rapid-Turnaround Solution to Get Quality Improvement Data into the Hands of Medical Specialists

    Author(s): Herrinton LJ; Liu L; Altschuler A; Dell R; Rabrenovich V; Compton-Phillips AL

    Perm J. 2015 Spring;19(2):15-21. Epub 2015-03-01.

    PubMed abstract

    Sexual Function and Health-Related Quality of Life in Long-Term Rectal Cancer Survivors

    Author(s): Sun V; Grant M; Wendel CS; McMullen CK; Bulkley JE; Herrinton LJ; Hornbrook MC; Krouse RS

    J Sex Med. 2016 Jul;13(7):1071-9.

    PubMed abstract

    Risk of Serious Infection for Patients with Systemic Lupus Erythematosus Starting Glucocorticoids with or without Antimalarials

    Author(s): Herrinton LJ; Liu L; Goldfien R; Michaels MA; Tran TN

    J Rheumatol. 2016 Jul 1.

    PubMed abstract

    Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster

    Author(s): Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR

    JAMA. 2013 Mar 6;309(9):887-95.

    PubMed abstract

    Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009

    Author(s): Herrinton LJ; Harrold L; Salman C; Liu L; Goldfien R; Asgari M; Gelfand JM; Wu JJ; Curtis JR

    Perm J. 2015 Dec 21.

    PubMed abstract

    Self-reported depression and perceived financial burden among long-term rectal cancer survivors

    Author(s): Chongpison Y; Hornbrook MC; Harris RB; Herrinton LJ; Gerald JK; Grant M; Bulkley JE; Wendel CS; Krouse RS

    Psychooncology. 2015 Sep 14.

    PubMed abstract

    Dietary and Behavioral Adjustments to Manage Bowel Dysfunction After Surgery in Long-Term Colorectal Cancer Survivors

    Author(s): Sun V; Grant M; Wendel CS; McMullen CK; Bulkley JE; Altschuler A; Ramirez M; Baldwin CM; Herrinton LJ; Hornbrook MC; Krouse RS

    Ann Surg Oncol. 2015 Jul 10.

    PubMed abstract

    Comparative Effectiveness of Laparoscopic Adjustable Gastric Banding vs Laparoscopic Gastric Bypass

    Author(s): Arterburn D; Powers JD; Toh S; Polsky S; Butler MG; Portz JD; Donahoo WT; Herrinton L; Williams RJ; Vijayadeva V; Fisher D; Bayliss EA

    JAMA Surg. 2014 Dec;149(12):1279-87.

    PubMed abstract

    Reliability and validity of a survey to measure bowel function and quality of life in long-term rectal cancer survivors

    Author(s): Wendel CS; Grant M; Herrinton L; Temple LK; Hornbrook MC; McMullen CK; Bulkley JE; Altschuler A; Krouse RS

    Qual Life Res. 2014 Dec;23(10):2831-40. Epub 2014-06-03.

    PubMed abstract

    Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study

    Author(s): Baddley JW; Winthrop KL; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR

    Ann Rheum Dis. 2014 Nov;73(11):1942-8. Epub 2013-07-13.

    PubMed abstract

    Trends in Elective Labor Induction for Six United States Health Plans, 2001-2007

    Author(s): Dublin S; Johnson KE; Walker RL; Avalos LA; Andrade SE; Beaton SJ; Davis RL; Herrinton LJ; Pawloski PA; Raebel MA; Smith DH; Toh S; Caughey AB

    J Womens Health (Larchmt). 2014 Nov;23(11):904-11. Epub 2014-10-20.

    PubMed abstract

    Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis

    Author(s): Wu JJ; Liu L; Asgari MM; Curtis JR; Harrold L; Salman C; Herrinton LJ

    J Eur Acad Dermatol Venereol. 2014 Oct;28(10):1380-7. Epub 2013-11-07.

    PubMed abstract

    New benchmark in preventing phacoemulsification-related endophthalmitis

    Author(s): Carnahan MC; Chang WJ; Shorstein NH; Herrinton LJ

    J Cataract Refract Surg. 2014 Sep;40(9):1568.

    PubMed abstract

    Pharmacotherapy for Incident Attention-Deficit/Hyperactivity Disorder: Practice Patterns and Quality Metrics

    Author(s): Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF

    Curr Med Res Opin. 2014 Aug;30(8):1687-99. Epub 2014-04-07.

    PubMed abstract

    From diagnosis through survivorship: health-care experiences of colorectal cancer survivors with ostomies

    Author(s): Sun V; Grant M; McMullen CK; Altschuler A; Mohler MJ; Hornbrook MC; Herrinton LJ; Krouse RS

    Support Care Cancer. 2014 Jun;22(6):1563-70. Epub 2014-01-19.

    PubMed abstract

    Racial and Ethnic Differences in Health Care Utilization and Outcomes Among Ulcerative Colitis Patients in an Integrated Health-Care Organization

    Author(s): Li D; Collins B; Velayos FS; Liu L; Lewis JD; Allison JE; Flowers NT; Hutfless S; Abramson O; Herrinton LJ

    Dig Dis Sci. 2014 Feb;59(2):287-94. Epub 2013-10-31.

    PubMed abstract

    Pharmacologic Therapies for the Management of Crohn's Disease: Comparative Effectiveness

    Author(s): Hutfless S; Almashat S; Berger Z; Wilson LM; Bonson E; Chen Q; Donath E; Herlong F; Puhan MA; Selvaraj S; Tuskey A; Vasilescu A; Bass EB; Worthington M; Shantha GPS; Lazarev M

    Rockville (MD): Agency for Healthcare Research and Quality (US); 2014.

    PubMed abstract

    Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009

    Author(s): Asgari MM; Wu JJ; Gelfand JM; Salman C; Curtis JR; Harrold LR; Herrinton LJ

    Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):842-9. Epub 2013-05-02.

    PubMed abstract

    Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996-2009

    Author(s): Harrold LR; Salman C; Shoor S; Curtis JR; Asgari MM; Gelfand JM; Wu JJ; Herrinton LJ

    J Rheumatol. 2013 Jul;40(7):1218-25. Epub 2013-04-15.

    PubMed abstract

    Initiation of Tumor Necrosis Factor Alpha (TNFalpha) antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases

    Author(s): Kawai VK; Grijalva CG; Arbogast PG; Curtis JR; Solomon DH; Delzell E; Chen L; Ouellet-Hellstrom R; Herrinton L; Liu L; Mitchell EF Jr; Stein CM; Griffin MR

    Arthritis Care Res (Hoboken). 2013 Jul;65(7):1085-94.

    PubMed abstract

    Drug safety data mining with a tree-based scan statistic

    Author(s): Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS

    Pharmacoepidemiol Drug Saf. 2013 May;22(5):517-23. Epub 2013 Mar 20.

    PubMed abstract

    Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual

    Author(s): Avery TR; Kulldorff M; Vilk Y; Li L; Cheetham TC; Dublin S; Davis RL; Liu L; Herrinton L; Brown JS

    Pharmacoepidemiol Drug Saf. 2013 May;22(5):488-95. Epub 2013 Feb 12.

    PubMed abstract

    Association between anti-TNF-alpha therapy and interstitial lung disease

    Author(s): Herrinton LJ; Harrold LR; Liu L; Raebel MA; Taharka A; Winthrop KL; Solomon DH; Curtis JR; Lewis JD; Saag KG

    Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):394-402. Epub 2013 Jan 29.

    PubMed abstract

    Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic

    Author(s): Brown JS; Petronis KR; Bate A; Zhang F; Dashevsky I; Kulldorff M; Avery TR; Davis RL; Chan KA; Andrade SE; Boudreau D; Gunter MJ; Herrinton L; Pawloski PA; Raebel MA; Roblin D; Smith D; Reynolds R

    Pharmaceutics. 2013 Mar 14;5(1):179-200.

    PubMed abstract

    Regarding: A Tale of Two Cohorts

    Author(s): Herrinton LJ

    Gastroenterology. 2013 Mar;144(3):e21-2. Epub 2013 Jan 25.

    PubMed abstract

    Tumor necrosis factor alpha inhibitor therapy and cancer risk in chronic immune mediated diseases

    Author(s): Haynes K; Beukelman T; Curtis JR; Newcomb C; Herrinton LJ; Graham DJ; Solomon DH; Griffin MR; Chen L; Liu L; Saag KG; Lewis JD; SABER Collaboration

    Arthritis Rheum. 2013 Jan;65(1):48-58.

    PubMed abstract

    Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department

    Author(s): Shorstein NH; Winthrop KL; Herrinton LJ

    J Cataract Refract Surg. 2013 Jan;39(1):8-14. Epub 2012 Oct 2.

    PubMed abstract

    Surviving Colorectal Cancer: Long-term, Persistent Ostomy-Specific Concerns and Adaptations

    Author(s): Sun V; Grant M; McMullen CK; Altschuler A; Mohler MJ; Hornbrook MC; Herrinton LJ; Baldwin CM; Krouse RS

    J Wound Ostomy Continence Nurs. 2013 Jan-Feb;40(1):61-72.

    PubMed abstract

    Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study

    Author(s): Winthrop KL; Chen L; Fraunfelder FW; Ku JH; Varley CD; Suhler E; Hills WL; Gattey D; Baddley JW; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Herrinton LJ; Fraunfelder FT; Saag KG; Lewis JD; Solomon DH; Curtis JR

    Am J Ophthalmol. 2013 Jan;155(1):183-189.e1. Epub 2012 Sep 8.

    PubMed abstract

    Mycobacterial diseases and antitumour necrosis factor therapy in USA

    Author(s): Winthrop KL; Baxter R; Liu L; Varley CD; Curtis JR; Baddley JW; McFarland B; Austin D; Radcliffe L; Suhler E; Choi D; Rosenbaum JT; Herrinton LJ

    Ann Rheum Dis. 2013 Jan;72(1):37-42. Epub 2012 Apr 20.

    PubMed abstract

    Association between anti-TNF-alpha therapy and all-cause mortality

    Author(s): Herrinton LJ; Liu L; Chen L; Harrold LR; Raebel MA; Curtis JR; Griffin MR; Solomon DH; Saag KG; Lewis JD

    Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1311-20. Epub 2012 Oct 15.

    PubMed abstract

    The association of psoriasis with autoimmune diseases

    Author(s): Wu JJ; Nguyen TU; Poon KY; Herrinton LJ

    J Am Acad Dermatol. 2012 Nov;67(5):924-30. Epub 2012 Jun 2.

    PubMed abstract

    Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey

    Author(s): Kawatkar AA; Jacobsen SJ; Levy GD; Medhekar SS; Venkatasubramaniam KV; Herrinton LJ

    Arthritis Care Res (Hoboken). 2012 Nov;64(11):1649-56.

    PubMed abstract

    Irrigation practices in long-term survivors of colorectal cancer with colostomies

    Author(s): Grant M; McMullen CK; Altschuler A; Hornbrook MC; Herrinton LJ; Wendel CS; Baldwin CM; Krouse RS

    Clin J Oncol Nurs. 2012 Oct;16(5):514-9.

    PubMed abstract

    Incidence and Mortality of Colorectal Adenocarcinoma in Persons with Inflammatory Bowel Disease from 1998 to 2010

    Author(s): Herrinton LJ; Liu L; Levin TR; Allison JE; Lewis JD; Velayos F

    Gastroenterology. 2012 Aug;143(2):382-9. Epub 2012 May 15.

    PubMed abstract

    Prenatal and Perinatal Characteristics Associated with Pediatric-Onset Inflammatory Bowel Disease

    Author(s): Hutfless S; Li DK; Heyman MB; Bayless TM; Abramson O; Herrinton LJ

    Dig Dis Sci. 2012 Aug;57(8):2149-56. Epub 2012 Mar 24.

    PubMed abstract

    Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

    Author(s): Toh S; Li L; Harrold LR; Bayliss EA; Curtis JR; Liu L; Chen L; Grijalva CG; Herrinton LJ

    Pharmacoepidemiol Drug Saf. 2012 May;21(5):524-34. Epub 2012 Mar 13.

    PubMed abstract

    The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program

    Author(s): Forrow S; Campion DM; Herrinton LJ; Nair VP; Robb MA; Wilson M; Platt R

    Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:12-7.

    PubMed abstract

    The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006

    Author(s): Herrinton LJ; Liu L; Abramson O; Jaffe ES

    Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):49-52. Epub 2011 Aug 8.

    PubMed abstract

    Initiation of Tumor Necrosis Factor-alpha Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases

    Author(s): Grijalva CG; Chen L; Delzell E; Baddley JW; Beukelman T; Winthrop KL; Griffin MR; Herrinton LJ; Liu L; Ouellet-Hellstrom R; Patkar NM; Solomon DH; Lewis JD; Xie F; Saag KG; Curtis JR

    JAMA. 2011 Dec 7;306(21):2331-9. Epub 2011 Nov 6.

    PubMed abstract

    Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease

    Author(s): Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE

    Am J Gastroenterol. 2011 Dec;106(12):2146-53. Epub 2011 Oct 25.

    PubMed abstract

    Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

    Author(s): Herrinton LJ; Curtis JR; Chen L; Liu L; Delzell E; Lewis JD; Solomon DH; Griffin MR; Ouellet-Hellstom R; Beukelman T; Grijalva CG; Haynes K; Kuriya B; Lii J; Mitchel E; Patkar N; Rassen J; Winthrop KL; Nourjah P; Saag KG

    Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1199-209. Epub 2011 Sep 15.

    PubMed abstract

    Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis

    Author(s): Kawai VK; Grijalva CG; Arbogast PG; Curtis JR; Solomon DH; Delzell E; Chen L; Ouellet-Hellstrom R; Herrinton L; Liu L; Mitchel EF Jr; Stein CM; Griffin MR

    Arthritis Care Res (Hoboken). 2011 Oct;63(10):1415-24.

    PubMed abstract

    Gender differences in quality of life among long-term colorectal cancer survivors with ostomies

    Author(s): Grant M; McMullen CK; Altschuler A; Mohler MJ; Hornbrook MC; Herrinton LJ; Wendel CS; Baldwin CM; Krouse RS

    Oncol Nurs Forum. 2011 Sep;38(5):587-96.

    PubMed abstract

    Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores

    Author(s): Hornbrook MC; Wendel CS; Coons SJ; Grant M; Herrinton LJ; Mohler MJ; Baldwin CM; McMullen CK; Green SB; Altschuler A; Rawl SM; Krouse RS

    Med Care. 2011 Mar;49(3):321-6.

    PubMed abstract

    The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy

    Author(s): Winthrop KL; Baxter R; Liu L; McFarland B; Austin D; Varley C; Radcliffe L; Suhler E; Choi D; Herrinton LJ

    Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):229-35. Epub 2010 Dec 10.

    PubMed abstract

    Urine bisphenol-A (BPA) level in relation to semen quality

    Author(s): Li DK; Zhou Z; Miao M; He Y; Wang J; Ferber J; Herrinton LJ; Gao E; Yuan W

    Fertil Steril. 2011 Feb;95(2):625-30.e1-4. Epub 2010 Oct 29.

    PubMed abstract

    Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system

    Author(s): Velayos FS; Liu L; Lewis JD; Allison JE; Flowers N; Hutfless S; Abramson O; Perry GS; Herrinton LJ

    Gastroenterology. 2010 Nov;139(5):1511-8. Epub 2010 Jul 24.

    PubMed abstract

    Relationship between urine bisphenol-A level and declining male sexual function

    Author(s): Li DK; Zhou Z; Miao M; He Y; Qing D; Wu T; Wang J; Weng X; Ferber J; Herrinton LJ; Zhu Q; Gao E; Yuan W

    J Androl. 2010 Sep-Oct;31(5):500-6. Epub 2010 May 13.

    PubMed abstract

    Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics

    Author(s): Rassen JA; Solomon DH; Curtis JR; Herrinton L; Schneeweiss S

    Med Care. 2010 Jun;48(6 Suppl):S83-9.

    PubMed abstract

    Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction

    Author(s): Li D; Zhou Z; Qing D; He Y; Wu T; Miao M; Wang J; Weng X; Ferber JR; Herrinton LJ; Zhu Q; Gao E; Checkoway H; Yuan W

    Hum Reprod. 2010 Feb;25(2):519-27. Epub 2009 Nov 10.

    PubMed abstract

    Early and late complications among long-term colorectal cancer survivors with ostomy or anastomosis

    Author(s): Liu L; Herrinton LJ; Hornbrook MC; Wendel CS; Grant M; Krouse RS

    Dis Colon Rectum. 2010 Feb;53(2):200-12.

    PubMed abstract

    Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization

    Author(s): Liu L; Allison JE; Herrinton LJ

    Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1086-93.

    PubMed abstract

    Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations

    Author(s): Lewis JD; Abramson O; Pascua M; Liu L; Asakura LM; Velayos FS; Hutfless SM; Alison JE; Herrinton LJ

    Clin Gastroenterol Hepatol. 2009 Nov;7(11):1195-201; quiz 1141-2. Epub 2009 Jul 22.

    PubMed abstract

    Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex

    Author(s): Krouse RS; Herrinton LJ; Grant M; Wendel CS; Green SB; Mohler MJ; Baldwin CM; McMullen CK; Rawl SM; Matayoshi E; Coons SJ; Hornbrook MC

    J Clin Oncol. 2009 Oct 1;27(28):4664-70. Epub 2009 Aug 31.

    PubMed abstract

    Gender differences in sleep disruption and fatigue on quality of life among persons with ostomies

    Author(s): Baldwin CM; Grant M; Wendel C; Hornbrook MC; Herrinton LJ; McMullen C; Krouse RS

    J Clin Sleep Med. 2009 Aug 15;5(4):335-43.

    PubMed abstract

    Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005

    Author(s): Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS

    Gastroenterology. 2009 Aug;137(2):502-11. Epub 2009 May 13.

    PubMed abstract

    Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels

    Author(s): He Y; Miao M; Herrinton LJ; Wu C; Yuan W; Zhou Z; Li DK

    Environ Res. 2009 Jul;109(5):629-33. Epub 2009 May 8.

    PubMed abstract

    Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations

    Author(s): Mazor KM; Sabin JE; Goff SL; Smith DH; Rolnick S; Roblin D; Raebel MA; Herrinton LJ; Gurwitz JH; Boudreau D; Meterko V; Dodd KS; Platt R

    Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):554-61.

    PubMed abstract

    Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations

    Author(s): Brown JS; Kulldorff M; Petronis KR; Reynolds R; Chan KA; Davis RL; Graham D; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R

    Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):226-34.

    PubMed abstract

    Exploring household income as a predictor of psychological well-being among long-term colorectal cancer survivors

    Author(s): Lundy JJ; Coons SJ; Wendel C; Hornbrook MC; Herrinton L; Grant M; Krouse RS

    Qual Life Res. 2009 Mar;18(2):157-61. Epub 2009 Jan 10.

    PubMed abstract

    Medication errors among adults and children with cancer in the outpatient setting

    Author(s): Walsh KE; Dodd KS; Seetharaman K; Roblin DW; Herrinton LJ; Von Worley A; Usmani GN; Baer D; Gurwitz JH

    J Clin Oncol. 2009 Feb 20;27(6):891-6. Epub 2008 Dec 29.

    PubMed abstract

    Patterns of infliximab use among Crohn's disease patients in a community setting

    Author(s): Pressman AR; Hutfless S; Velayos F; Fireman B; Lewis JD; Allison J; Abramson O; Herrinton LJ

    Inflamm Bowel Dis. 2008 Sep;14(9):1265-72.

    PubMed abstract

    Screening differences and risk of cervical cancer in inflammatory bowel disease

    Author(s): Hutfless S; Fireman B; Kane S; Herrinton LJ

    Aliment Pharmacol Ther. 2008 Sep 1;28(5):598-605. Epub 2008 Jun 28.

    PubMed abstract

    Natural history of severe ulcerative colitis in a community-based health plan

    Author(s): Allison J; Herrinton LJ; Liu L; Yu J; Lowder J

    Clin Gastroenterol Hepatol. 2008 Sep;6(9):999-1003.

    PubMed abstract

    Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002

    Author(s): Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J

    Am J Gastroenterol. 2008 Aug;103(8):1998-2006.

    PubMed abstract

    Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease

    Author(s): Altschuler A; Collins B; Lewis JD; Velayos F; Allison JE; Hutfless S; Liu L; Herrinton LJ

    Inflamm Bowel Dis. 2008 Jul;14(7):992-9.

    PubMed abstract

    The health-related quality of life in long-term colorectal cancer survivors study: objectives, methods and patient sample

    Author(s): Mohler MJ; Coons SJ; Hornbrook MC; Herrinton LJ; Wendel CS; Grant M; Krouse RS

    Curr Med Res Opin. 2008 Jul;24(7):2059-70. Epub 2008 Jun 9.

    PubMed abstract

    Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

    Author(s): Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L

    J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. Epub 2008 Apr 8.

    PubMed abstract

    Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network

    Author(s): Aiello EJ; Buist DS; Wagner EH; Tuzzio L; Greene SM; Lamerato LE; Field TS; Herrinton LJ; Haque R; Hart G; Bischoff KJ; Geiger AM

    Breast Cancer Res Treat. 2008 Feb;107(3):397-403. Epub 2007 Mar 28.

    PubMed abstract

    Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy

    Author(s): Altschuler A; Nekhlyudov L; Rolnick SJ; Greene SM; Elmore JG; West CN; Herrinton LJ; Harris EL; Fletcher SW; Emmons KM; Geiger AM

    Breast J. 2008 Jan-Feb;14(1):25-32.

    PubMed abstract

    Mortality by medication use among patients with inflammatory bowel disease, 1996-2003

    Author(s): Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ

    Gastroenterology. 2007 Dec;133(6):1779-86. Epub 2007 Sep 26.

    PubMed abstract

    Early detection of adverse drug events within population-based health networks: application of sequential testing methods

    Author(s): Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R

    Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275-84.

    PubMed abstract

    Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans

    Author(s): Mazor KM; Sabin JE; Boudreau D; Goodman MJ; Gurwitz JH; Herrinton LJ; Raebel MA; Roblin D; Smith DH; Meterko V; Platt R

    Med Care. 2007 Oct;45(10 Supl 2):S29-37.

    PubMed abstract

    Quality of diabetes care among cancer survivors with diabetes

    Author(s): Keating NL; Zaslavsky AM; Herrinton LJ; Selby JV; Wolf RE; Ayanian JZ

    Med Care. 2007 Sep;45(9):869-75.

    PubMed abstract

    Complications at the end of life in ovarian cancer

    Author(s): Herrinton LJ; Neslund-Dudas C; Rolnick SJ; Hornbrook MC; Bachman DJ; Darbinian JA; Jackson JM; Coughlin SS

    J Pain Symptom Manage. 2007 Sep;34(3):237-43. Epub 2007 Jul 2.

    PubMed abstract

    Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization

    Author(s): Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ

    Am J Gastroenterol. 2007 Jul;102(7):1429-35. Epub 2007 Apr 16.

    PubMed abstract

    What women wish they knew before prophylactic mastectomy

    Author(s): Rolnick SJ; Altschuler A; Nekhlyudov L; Elmore JG; Greene SM; Harris EL; Herrinton LJ; Barton MB; Geiger AM; Fletcher SW

    Cancer Nurs. 2007 Jul-Aug;30(4):285-91; quiz 292-3.

    PubMed abstract

    Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings

    Author(s): Herrinton LJ; Liu L; Lafata JE; Allison JE; Andrade SE; Korner EJ; Chan KA; Platt R; Hiatt D; O'Connor S

    Inflamm Bowel Dis. 2007 Apr;13(4):451-61.

    PubMed abstract

    Specificity of clinical breast examination in community practice

    Author(s): Fenton JJ; Rolnick SJ; Harris EL; Barton MB; Barlow WE; Reisch LM; Herrinton LJ; Geiger AM; Fletcher SW; Elmore JG

    J Gen Intern Med. 2007 Mar;22(3):332-7.

    PubMed abstract

    Racial differences in tumor stage and survival for colorectal cancer in an insured population

    Author(s): Doubeni CA; Field TS; Buist DS; Korner EJ; Bigelow C; Lamerato L; Herrinton L; Quinn VP; Hart G; Hornbrook MC; Gurwitz JH; Wagner EH

    Cancer. 2007 Feb 1;109(3):612-20.

    PubMed abstract

    Quality of life after bilateral prophylactic mastectomy

    Author(s): Geiger AM; Nekhlyudov L; Herrinton LJ; Rolnick SJ; Greene SM; West CN; Harris EL; Elmore JG; Altschuler A; Liu IL; Fletcher SW; Emmons KM

    Ann Surg Oncol. 2007 Feb;14(2):686-94. Epub 2006 Nov 11.

    PubMed abstract

    Pain management in the last six months of life among women who died of ovarian cancer

    Author(s): Rolnick SJ; Jackson J; Nelson WW; Butani A; Herrinton LJ; Hornbrook M; Neslund-Dudas C; Bachman DJ; Coughlin SS

    J Pain Symptom Manage. 2007 Jan;33(1):24-31.

    PubMed abstract

    Recent declines in hormone therapy utilization and breast cancer incidence; clinical and population-based evidence

    Author(s): Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ

    J Clin Oncol. 2006 Nov 20;24(33):e49-50.

    PubMed abstract

    Variations in hospice use among cancer patients

    Author(s): Keating NL; Herrinton LJ; Zaslavsky AM; Liu L; Ayanian JZ

    J Natl Cancer Inst. 2006 Aug 2;98(15):1053-9.

    PubMed abstract

    Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy

    Author(s): Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW

    J Clin Oncol. 2006 Mar 20;24(9):1350-6.

    PubMed abstract

    Efficacy of breast cancer screening in the community according to risk level

    Author(s): Elmore JG; Reisch LM; Barton MB; Barlow WE; Rolnick S; Harris EL; Herrinton LJ; Geiger AM; Beverly RK; Hart G; Yu O; Greene SM; Weiss NS; Fletcher SW

    J Natl Cancer Inst. 2005 Jul 20;97(14):1035-43.

    PubMed abstract

    Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project

    Author(s): Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW

    J Clin Oncol. 2005 Jul 1;23(19):4275-86. Epub 2005 Mar 28.

    PubMed abstract

    A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices

    Author(s): Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW

    Arch Intern Med. 2005 Mar 14;165(5):516-20.

    PubMed abstract

    Women's decision-making roles regarding contralateral prophylactic mastectomy

    Author(s): Nekhlyudov L; Bower M; Herrinton LJ; Altschuler A; Greene SM; Rolnick S; Elmore JG; Harris EL; Liu A; Emmons KM; Fletcher SW; Geiger AM

    J Natl Cancer Inst Monogr. 2005;(35):55-60.

    PubMed abstract

    Complications following bilateral prophylactic mastectomy

    Author(s): Barton MB; West CN; Liu IL; Harris EL; Rolnick SJ; Elmore JG; Herrinton LJ; Greene SM; Nekhlyudov L; Fletcher SW; Geiger AM

    J Natl Cancer Inst Monogr. 2005;(35):61-6.

    PubMed abstract

    Screening clinical breast examination: how often does it miss lethal breast cancer?

    Author(s): Fenton JJ; Barton MB; Geiger AM; Herrinton LJ; Rolnick SJ; Harris EL; Barlow WE; Reisch LM; Fletcher SW; Elmore JG

    J Natl Cancer Inst Monogr. 2005;(35):67-71.

    PubMed abstract

    Race and ethnicity: comparing medical records to self-reports

    Author(s): West CN; Geiger AM; Greene SM; Harris EL; Liu IL; Barton MB; Elmore JG; Rolnick S; Nekhlyudov L; Altschuler A; Herrinton LJ; Fletcher SW; Emmons KM

    J Natl Cancer Inst Monogr. 2005;(35):72-4.

    PubMed abstract

    Building a research consortium of large health systems: the Cancer Research Network

    Author(s): Wagner EH; Greene SM; Hart G; Field TS; Fletcher S; Geiger AM; Herrinton LJ; Hornbrook MC; Johnson CC; Mouchawar J; Rolnick SJ; Stevens VJ; Taplin SH; Tolsma D; Vogt TM

    J Natl Cancer Inst Monogr. 2005;(35):3-11.

    PubMed abstract

    Disparities and survival among breast cancer patients

    Author(s): Field TS; Buist DS; Doubeni C; Enger S; Fouayzi H; Hart G; Korner EJ; Lamerato L; Bachman DJ; Ellis J; Herrinton L; Hornbrook MC; Krajenta R; Liu L; Yao J

    J Natl Cancer Inst Monogr. 2005;(35):88-95.

    PubMed abstract

    Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data

    Author(s): Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW

    Am J Manag Care. 2004 Apr;10(4):257-62.

    PubMed abstract

    Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network

    Author(s): Field TS; Cernieux J; Buist D; Geiger A; Lamerato L; Hart G; Bachman D; Krajenta R; Greene S; Hornbrook MC; Ansell G; Herrinton L; Reed G

    J Natl Cancer Inst. 2004 Jan 21;96(2):148-52.

    PubMed abstract

    A cohort study of systemic and local complications of toe prostheses

    Author(s): Husson G; Herrinton LJ; Brox WT; Finkle W; Bernstein A; Shoor S; Greenland S

    Am J Orthop (Belle Mead NJ). 2003 Dec;32(12):585-92.

    PubMed abstract

    Regarding 'a case-control study of sexually transmitted disease and risk of testicular cancer'

    Author(s): Husson G; Herrinton LJ

    Ann Epidemiol. 2003 Aug;13(7):541-2.

    PubMed abstract

    A computerized system to facilitate medical record abstraction in cancer research (United States)

    Author(s): Geiger AM; Greene SM; Pardee RE 3rd; Hart G; Herrinton LJ; Macedo AM; Rolnick S; Harris EL; Barton MB; Elmore JG; Fletcher SW

    Cancer Causes Control. 2003 Jun;14(5):469-76.

    PubMed abstract

    Management of cryptorchism and risk of testicular cancer

    Author(s): Herrinton LJ; Zhao W; Husson G

    Am J Epidemiol. 2003 Apr 1;157(7):602-5.

    PubMed abstract

    Training, quality assurance, and assessment of medical record abstraction in a multisite study

    Author(s): Reisch LM; Fosse JS; Beverly K; Yu O; Barlow WE; Harris EL; Rolnick S; Barton MB; Geiger AM; Herrinton LJ; Greene SM; Fletcher SW; Elmore JG

    Am J Epidemiol. 2003 Mar 15;157(6):546-51.

    PubMed abstract

    Regarding: a cohort study of systemic and local complications following implantation of testicular prostheses

    Author(s): Herrinton LJ; Brox T; Greenland S; Finkle WD; Cattolica E; Shoor S

    Ann Epidemiol. 2003 Jan;13(1):73-7.

    PubMed abstract

    Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization

    Author(s): McGuire V; Herrinton L; Whittemore AS

    Epidemiology. 2002 Mar;13(2):231-4.

    PubMed abstract

    Risk factors for synchronous primary endometrial and ovarian cancers

    Author(s): Herrinton LJ; Voigt LF; Weiss NS; Beresford SA; Wingo PA

    Ann Epidemiol. 2001 Nov;11(8):529-33.

    PubMed abstract

    Relation of childhood height and later risk of breast cancer

    Author(s): Herrinton LJ; Husson G

    Am J Epidemiol. 2001 Oct 1;154(7):618-23.

    PubMed abstract

    How accurately does the medical record capture maternal history of cancer?

    Author(s): Husson G; Herrinton LJ

    Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):765-8.

    PubMed abstract

    Epidemiology of the Revised European-American Lymphoma Classification subtypes

    Author(s): Herrinton LJ

    Epidemiol Rev. 1998;20(2):187-203.

    PubMed abstract

    Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes

    Author(s): Herrinton LJ; Friedman GD

    Cancer Epidemiol Biomarkers Prev. 1998 Jan;7(1):25-8.

    PubMed abstract